Most Popular Choices
Share on Facebook 1 Printer Friendly Page More Sharing
General News   

Medicare drug card problem plagued with snafus; Some seniors got barbituate discounts

Quicklink Submitted By   No comments
Message Amanda Lang
Become a Fan
  (9 fans)
Congressional investigators said Wednesday that they had found serious, widespread problems in a government program that issued drug discount cards to 6.4 million Medicare beneficiaries, as a precursor to the full-fledged drug benefit that takes effect next year, the New York Times will report in Thursday's papers.

The range of problems included inaccurate, incomplete information about how the program should work -- from the government, insurance companies and pharmacy officials -- and improper use of the cards to pay for barbiturates and other drugs they were forbidden to cover.
Read the rest of the story HERE:

At rawstory.com
Rate It | View Ratings

Amanda Lang Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

OpedNews volunteer from 2005 to 2013.

Amanda Lang was a wonderful member of the Opednews team, and the first volunteer editor, for a good number of years being a senior editor. She passed away summer 2014.

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation:

Tell A Friend